Breast cancer-related data |
|
Location |
|
left |
23 (59.0) |
right |
13 (33.3) |
bilateral |
3 (7.7) |
Stage at diagnosis |
|
I |
9 (23.1) |
II |
21 (53.8) |
III |
8 (20.5) |
IV |
1 (2.6) |
Surgery type |
|
Lumpectomy/Segmental |
17 (43.6) |
Modified radical mastectomy |
16 (41.0) |
Radical mastectomy |
3 (7.7) |
Other |
3 (7.7) |
Chemotherapy type |
|
Cytoxan Adriamycin 5Fu |
3 (7.7) |
Adriamycin Cytoxan |
10 (25.6) |
Cytoxin Methatrexate 5fu |
4 (10.3) |
Other/Missing/None |
22 (56.4) |
Radiation |
|
None |
11 (28.2) |
Some |
28 (71.8) |
Complete treatment received |
|
Surgery alone |
2 (5.1) |
Surgery and radiation |
1 (2.6) |
Surgery and chemotherapy |
9 (23.1) |
Surgery, radiation, and chemotherapy |
27 (69.2) |
Time since breast cancer diagnosis, Mean ± SD (years) |
8.57±6.74 |
|
Lymphedema Data |
|
Location |
|
Left arm |
23 (59.0) |
Right arm |
16 (41.0) |
Lymphedema dominant arm |
18 (46.2) |
BMI Group |
|
<30 |
19 (48.7) |
≥30 |
20 (51.3) |
Lymphedema duration, Mean ± SD (years) |
5.75±4.06 |
Lymphedema onset since breast cancer diagnosis, Mean ± SD (years) |
2.74±5.65 |